Form 8-K - Current report:
SEC Accession No. 0001437749-20-006154
Filing Date
2020-03-26
Accepted
2020-03-26 08:05:41
Documents
2
Period of Report
2020-03-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K atos20200319_8k.htm 8-K 35151
2 EXHIBIT 99.1 ex_178149.htm EX-99.1 117100
  Complete submission text file 0001437749-20-006154.txt   153431
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

EIN.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35610 | Film No.: 20744226
SIC: 2834 Pharmaceutical Preparations